Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Sep-Oct;1(2):115-122.
doi: 10.1016/j.ogla.2018.08.007. Epub 2018 Aug 25.

Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques

Eric Rh Duerr #  1 , Mohamed S Sayed #  1 , Stephen Moster  1 , Timothy Holley  1 , Jin Peiyao  1 , Elizabeth A Vanner  1 , Richard K Lee  1
Affiliations
Comparative Study

Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques

Eric Rh Duerr et al. Ophthalmol Glaucoma. 2018 Sep-Oct.

Abstract

Purpose: To compare the outcomes of standard pop-titrated transscleral cyclophotocoagulation (TSCPC) and slow-coagulation TSCPC in the treatment of glaucoma.

Design: Retrospective case series.

Subjects: This study included 78 eyes with glaucoma of any type or stage that underwent TSCPC as part of their treatment course.

Methods: This study compared 52 eyes treated with slow coagulation TSCPC to 26 eyes treated with standard pop-titrated TSCPC. Patient demographics, treatment course, surgical techniques, settings and outcomes were assessed.

Main outcome measures: The main outcome measures were visual acuity (VA), intraocular pressure (IOP) and post-surgical complications.

Results: The initial LogMAR VA was 1.94 (0.73) [mean (SD)] in the slow coagulation TSCPC group and 1.71 (0.90) in the standard TSCPC group (p=0.507). Initial IOP was 37 (13) mm Hg in the slow coagulation group and 39 (13) mm Hg in the standard group (p=0.297). The follow-up periods were 16.36 months and 24.68 months for the slow coagulation and standard groups (p=0.124). VA remained better than light-perception in 71.1% of slow coagulation treated patients and 65.0% of standard TSCPC treated patients (p=0.599). IOP remained below 20 mm Hg in 46% of slow coagulation treated patients and 44% of standard TSCPC treated patients (p=0.870). The mean number of complications was higher in the standard group [1.46 (1.24)] versus the slow coagulation group [0.62 (0.75)] (p=0.002). The incidence of the need for a second procedure (slow coagulation- 28.8%, standard- 23.1%, p=0.588) and maximum number of medications needed to control IOP postoperatively (p=0.771) were similar between the two groups.

Conclusions: In this case series, slow coagulation TSCPC and standard pop-titrated TSCPC resulted in similar VA and IOP outcomes in the treatment of glaucomatous eyes. The complication profiles of the techniques were also comparable, although standard TSCPC had a higher incidence of prolonged inflammation postoperatively. This study suggests that slow coagulation TSCPC may achieve equivalent control of IOP while reducing the incidence of prolonged post-operative inflammation-a feared complication of TSCPC-when compared to standard "pop-titrated" TSCPC.

Keywords: CPC; cyclophotocoagulation; diode laser CPC; glaucoma.

PubMed Disclaimer

Conflict of interest statement

b- Financial Disclosures: All authors have no conflicts of interest regarding any of the products or material discussed in this article.

Figures

Figure 1:
Figure 1:
Patient inclusion and exclusion flowchart
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Weve H Die Zyklodiatermie das Corpus ciliare bei Glaukom. Zentralbl Ophthalmol 1933;29:562–569.
    1. Vogt A Versuche zur intraokularen Druckherabsetzung mittels Diatermieschadigung des Corpus ciliare (Zyklodiatermiestichelung). Klin Monatsbl Augenheilkd 1936;97:672–677.
    1. Haik GM, Breffeilh LA, Barber A. Beta irradiation as a possible therapeutic agent in glaucoma; an experimental study with the report of a clinical case. American journal of ophthalmology 1948;31:945–52. - PubMed
    1. Berens C, Sheppard LB, Duel AB. Cycloelectrolysis for glaucoma. Transactions of the American Ophthalmological Society 1949;47:364–82. - PMC - PubMed
    1. Berens C Glaucoma surgery; an evaluation of cycloelectrolysis and cyclodiathermy. AMA archives of ophthalmology 1955;54:548–63. - PubMed

Publication types